Market Overview:
The global multiplex detection immunoassay market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for accurate and rapid diagnostics, technological advancements in multiplex detection immunoassays, and rising prevalence of chronic diseases. The nucleic acid-based techniques segment is expected to dominate the global multiplex detection immunoassay market in terms of revenue during the forecast period. This segment is anticipated to grow at a CAGR of 11.1% from 2018 to 2030 owing to its advantages such as high accuracy and specificity, ability to detect low-abundance targets, and wide range of applications. The pharmaceutical companies segment is projected to account for the largest share of the global multiplex detection immunoassay market in 2018. This segment is estimated account for 43% share by revenue in 2018 and is projected register a CAGR of 10%.
Product Definition:
A multiplex detection immunoassay is a technique used to detect and quantify several analytes in a single sample. The importance of multiplex detection immunoassays lies in their ability to simultaneously measure many different biomarkers, which can provide more comprehensive information about the health or disease state of a patient. This technology has the potential to improve diagnosis and treatment by allowing healthcare providers to track changes in biomarker levels over time.
Nucleic Acid Based Techniques:
Nucleic acid based techniques are expected to witness significant growth in the next seven years owing to its wide range of applications. The nucleic acid-based techniques have been applied in molecular diagnostics, drug discovery & development, gene expression analysis and many other areas. This technology is expected to grow at a lucrative CAGR due to increasing demand for rapid diagnostic tests coupled with rising investments by market players for the advancement of this technology.
Protein Based Multiplex Techniques:
Protein based multiplex techniques and it's usage in Multiplex Detection Immunoassay market is expected to grow at a significant rate over the forecast period. The growth of this market can be attributed to factors such as rising prevalence of chronic diseases, increasing demand for personalized medicines, technological advancements in immunoassays and protein-based multiplexing techniques. Furthermore, growing awareness about these products among physicians is also expected to boost the market growth during the forecast period.
Application Insights:
On the basis of application, the market is segmented into pharmaceutical companies, clinical research organizations, food & beverage companies, academic research institutes, diagnostic centers and biotechnology companies. The pharmaceutical companies are expected to dominate the market throughout the forecast period owing to increasing product launches for multiplex immunoassays in various applications such as infectious diseases testing and cancer screening. For instance; in April 2017 Roche launched a new pan-cancer panel that includes CEA I&II assays for biomarker discovery.
The clinical research organization segment is also anticipated to witness lucrative growth over the forecast period due to an increase in R&D activities pertaining to new drug development and other advanced therapeutics. Increasing number of Phase III studies along with stable growth witnessed by these organizations during recent years is expected drive demand for MIDA 20 (multiplex immunoassay on a chip).
Regional Analysis:
North America dominated the global multiplex detection immunoassay market in 2017. This can be attributed to factors such as local presence of major players, high disposable income, and increasing adoption of technologically advanced products. Moreover, growing focus on quality healthcare and rising demand for point-of-care diagnostics are expected to drive the regional market over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to untapped opportunities in this region along with rapid economic development coupled with improving healthcare infrastructure & affordability issues faced by patients & physicians in this region need urgent attention from government agencies for better diagnosis & treatment options leading towards improved health outcomes thus driving growth potentials of this industry within Asia Pacific region.
Growth Factors:
- Increasing demand for rapid and accurate diagnostic tests
- Rising prevalence of target diseases
- Technological advancements in immunoassay platforms
- Growing number of collaborations and partnerships among assay developers, manufacturers, and distributors
- Increasing investments in R&D for novel multiplex detection immunoassays
Scope Of The Report
Report Attributes
Report Details
Report Title
Multiplex Detection Immunoassay Market Research Report
By Type
Nucleic Acid Based Techniques, Protein Based Multiplex Techniques, Biosensor Based Techniques
By Application
Pharmaceutical Companies, Clinical Research Organizations, Food & Beverages Companies, Academic Research Institutes, Diagnostic Centers, Biotechnology Companies
By Companies
Bio-Rad, Thermo Fisher Scientific, EMD Millipore, Microsynh, Quansys Bioscience, BD Biosciences, Qiagen, Roche, Danaher, Unisensor, Luminex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Multiplex Detection Immunoassay Market Report Segments:
The global Multiplex Detection Immunoassay market is segmented on the basis of:
Types
Nucleic Acid Based Techniques, Protein Based Multiplex Techniques, Biosensor Based Techniques
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Companies, Clinical Research Organizations, Food & Beverages Companies, Academic Research Institutes, Diagnostic Centers, Biotechnology Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad
- Thermo Fisher Scientific
- EMD Millipore
- Microsynh
- Quansys Bioscience
- BD Biosciences
- Qiagen
- Roche
- Danaher
- Unisensor
- Luminex
Highlights of The Multiplex Detection Immunoassay Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nucleic Acid Based Techniques
- Protein Based Multiplex Techniques
- Biosensor Based Techniques
- By Application:
- Pharmaceutical Companies
- Clinical Research Organizations
- Food & Beverages Companies
- Academic Research Institutes
- Diagnostic Centers
- Biotechnology Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Multiplex Detection Immunoassay Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Multiplex detection immunoassay is a type of immunoassay that uses multiple antibodies to detect a particular antigen.
Some of the key players operating in the multiplex detection immunoassay market are Bio-Rad, Thermo Fisher Scientific, EMD Millipore, Microsynh, Quansys Bioscience, BD Biosciences, Qiagen, Roche, Danaher, Unisensor, Luminex.
The multiplex detection immunoassay market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Multiplex Detection Immunoassay Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Multiplex Detection Immunoassay Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Multiplex Detection Immunoassay Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Multiplex Detection Immunoassay Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Multiplex Detection Immunoassay Market Size & Forecast, 2020-2028
4.5.1 Multiplex Detection Immunoassay Market Size and Y-o-Y Growth
4.5.2 Multiplex Detection Immunoassay Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Nucleic Acid Based Techniques
5.2.2 Protein Based Multiplex Techniques
5.2.3 Biosensor Based Techniques
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical Companies
6.2.2 Clinical Research Organizations
6.2.3 Food & Beverages Companies
6.2.4 Academic Research Institutes
6.2.5 Diagnostic Centers
6.2.6 Biotechnology Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Multiplex Detection Immunoassay Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Multiplex Detection Immunoassay Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Nucleic Acid Based Techniques
9.6.2 Protein Based Multiplex Techniques
9.6.3 Biosensor Based Techniques
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical Companies
9.10.2 Clinical Research Organizations
9.10.3 Food & Beverages Companies
9.10.4 Academic Research Institutes
9.10.5 Diagnostic Centers
9.10.6 Biotechnology Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Nucleic Acid Based Techniques
10.6.2 Protein Based Multiplex Techniques
10.6.3 Biosensor Based Techniques
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical Companies
10.10.2 Clinical Research Organizations
10.10.3 Food & Beverages Companies
10.10.4 Academic Research Institutes
10.10.5 Diagnostic Centers
10.10.6 Biotechnology Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Nucleic Acid Based Techniques
11.6.2 Protein Based Multiplex Techniques
11.6.3 Biosensor Based Techniques
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical Companies
11.10.2 Clinical Research Organizations
11.10.3 Food & Beverages Companies
11.10.4 Academic Research Institutes
11.10.5 Diagnostic Centers
11.10.6 Biotechnology Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Nucleic Acid Based Techniques
12.6.2 Protein Based Multiplex Techniques
12.6.3 Biosensor Based Techniques
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical Companies
12.10.2 Clinical Research Organizations
12.10.3 Food & Beverages Companies
12.10.4 Academic Research Institutes
12.10.5 Diagnostic Centers
12.10.6 Biotechnology Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Nucleic Acid Based Techniques
13.6.2 Protein Based Multiplex Techniques
13.6.3 Biosensor Based Techniques
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical Companies
13.10.2 Clinical Research Organizations
13.10.3 Food & Beverages Companies
13.10.4 Academic Research Institutes
13.10.5 Diagnostic Centers
13.10.6 Biotechnology Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Multiplex Detection Immunoassay Market: Competitive Dashboard
14.2 Global Multiplex Detection Immunoassay Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad
14.3.2 Thermo Fisher Scientific
14.3.3 EMD Millipore
14.3.4 Microsynh
14.3.5 Quansys Bioscience
14.3.6 BD Biosciences
14.3.7 Qiagen
14.3.8 Roche
14.3.9 Danaher
14.3.10 Unisensor
14.3.11 Luminex
